Yang, Xiaoqin http://orcid.org/0000-0003-1806-1592
Yoo, Hyun Kyoo
Amin, Suvina
Cheng, Wendy Y.
Sundaresan, Sanjana
Zhang, Lujia
Duh, Mei Sheng
Funding for this research was provided by:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
AstraZeneca UK Limited
Article History
Received: 12 November 2021
Accepted: 26 March 2022
First Online: 17 May 2022
Declarations
:
: This retrospective survey study was conducted in accordance with the ethical standards of the Declaration of Helsinki. The study was approved by the WCG IRB.
: All participants signed an informed consent form regarding the publication of the data they contributed to this study.
: Informed consent to participate in the study was obtained from all participants aged 18 years and older. Pediatric participants aged between 8 and 17 years provided their assent to participate, and their parent or legal guardian consented to their child’s participation.
: XY is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and owns stock in Merck & Co., Inc., Kenilworth, NJ, USA. HKY is an employee of AstraZeneca and owns stock. SA was an employee of AstraZeneca and owned stock during the conduct of the study. WYC, SS, LZ, and MSD are employees of Analysis Group, Inc., which received funding from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, in collaboration with AstraZeneca UK Limited for the conduct of the present study.